Green tea catechins in chemoprevention of cancer: A molecular docking investigation into their interaction with glutathione S-transferase (GST P1-1)

References

• YA Elsayad, and EA Sausville. (2001). Selected novel anticancer treatments targeting cell signaling proteins. Oncologist 6:517–537.
   PubMedGoogle Scholar
• MM Gottesman, and I Pastan. (1993). Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann Rev Biochem 62:385–427.
   PubMed Web of Science ®Google Scholar
• RN Armstrong. (1997). Structure, catalytic machanism, and evolution of the glutathione transferase. Chem Res Toxicol 10:2–18.
   PubMed Web of Science ®Google Scholar
• DL Eaton, and TK Bammler. (1999). Concise review of the glutathione S-transferase and their significance to toxicology. Toxicol Sci 49:156–164.
   PubMed Web of Science ®Google Scholar
• DM Townsend, and KD Tew. (2003). The role of glutathione-S-transferase in anti-cancer drug resistance. Oncogene 22:7369–7375.
   PubMed Web of Science ®Google Scholar
• ML O'Brien, and KD Tew. (1996). Glutathione and related enzymes in multidrug resistance. Eur J Cancer 32A:967–978.
   PubMed Web of Science ®Google Scholar
• MCJ Wilce, and MW Parker. (1994). Structure and function of glutathione S-transferases. Biochim Biophys Acta 1–18.
   PubMedGoogle Scholar
• C Anderson, E Mosialou, R Weinander, and R Morgenstern. (1994). Enzymology of microsomal glutathione S-transferase. Adv Pharmacol 27:19–35.
   PubMedGoogle Scholar
• PJ Jakobsson, JA Mancini, and AW Ford-Hutchinson. (1996). Identification and characterization of a novel human microsomal glutathione S-transferase with leukotriene C4 synthase activity and significant sequence identity to 5-lipoxygenase-activating protein and leukotriene C4 synthase. J Biol Chem 271:22203–22210.
   PubMed Web of Science ®Google Scholar
• SE Pemble, AF Wardle, and JB Taylor. (1996). Glutathione S-transferase class Kappa: Characterization by the cloning of rat mitochondrial GST and identification of a human homologue. Biochem J 319:749–754.
   PubMed Web of Science ®Google Scholar
• B Mannervik, PA lin, C Guthenberg, H Jensson, MK Tahir, M Warholm, and H Jornvall. (1985). Identification of three classes of cytosolic glutathione transferase common to several mammalian species: Correlation between structural data and enzymatic properties. Proc Natl Acad Sci USA 82:7202–7206.
   PubMed Web of Science ®Google Scholar
• DJ Meyer, B Coles, SE Pemble, KS Gilmore, GM Fraser, and B Ketterer. (1991). Theta, a new class of glutathione transferases purified from rat and man. Biochem J 274:409–414.
   PubMed Web of Science ®Google Scholar
• DJ Meyer, and M Thomas. (1995). Characterization of rat spleen prostaglandin H D-isomerase as a sigma-class GSH transferase. Biochem J 311:739–742.
   PubMed Web of Science ®Google Scholar
• B Mannervik. (1985). The isoenzymes of glutathione transferase. Adv Enzymol 57:357–417.
   PubMedGoogle Scholar
• MA Watson, RK Stewart, GB Smith, and et al (1998). Human glutathione S-transferase P1 polymorphisms: Relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis 19:275–280.
   PubMed Web of Science ®Google Scholar
• M Michael, and MM Doherty. (2005). Tumoral drug metabolism: Overview and its implications for cancer therapy. J Clin Oncol 23 (1):205–229.
   PubMedGoogle Scholar
• B Coles, and B Ketterer. (1990). The role of glutathione transferases in chemical carcinogenesis. CRC Crit Rev Biochem Mol Biol 25:47–70.
   PubMed Web of Science ®Google Scholar
• JD Hayes, and DJ Pulford. (1995). The glutathione S-transferase supergene familyregulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. CRC Crit Rev Biochem Mol Biol 30:445–600.
   PubMed Web of Science ®Google Scholar
• S Tsuchida, and K Sato. (1992). Glutathione transferases and cancer. CRC Crit Rev Biochem Mol Biol 27:337–384.
   PubMed Web of Science ®Google Scholar
• DJ Waxman. (1990). Glutathione-S-transferases: Role in alkylating agent resistance and possible target for modulation chemotherapy-a review. Cancer Res 50:6449–6454.
   PubMed Web of Science ®Google Scholar
• JA Montali, JB Wheatley, and DE Schmidt. (1995). Comparison of glutathione S-transferase levels in predicting the efficacy of a novel alkylating agent. Cellular Pharmacol 2:241–247.
   Google Scholar
• AS Morgan, PJ Ciaccio, KD Tew, and LM Kauvar. (1996). Isozyme-specific glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human tumor cell lines. Cancer Chemother Pharmacol 37:363–370.
   PubMed Web of Science ®Google Scholar
• Y Ohno, K Wakai, K Genka, K Ohmine, T Kawamura, A Tamakoshi, R Aoki, M Senda, Y Hayashi, K Nagao, and et al (1995). Tea consumption and lung cancer risk: A case-control study in Okinawa, Japan. Jpn J Cancer Res 86:1027–1034.
   PubMedGoogle Scholar
• L Zhong, MS Goldberg, YT Gao, JA Hanley, ME Parent, and F Jin. (2001). A population-based case-control study of lung cancer and green tea consumption among women living in Shanghai, China. Epidemiology 12:695–700.
   PubMed Web of Science ®Google Scholar
• BT Ji, WH Chow, AW Hsing, JK McLaughlin, Q Dai, YT Gao, WJ Blot, and JF FraumeniJr. (1997). Green tea consumption and the risk of pancreatic and colorectal cancers. Int J Cancer 70:255–258.
   PubMed Web of Science ®Google Scholar
• M Inoue, K Tajima, M Mizutani, H Iwata, T Iwase, S Miura, K Hirose, N Hamajima, and S Tominaga. (2001). Regular consumption of green tea and the risk of breast cancer recurrence: Follow-up study from the hospital-based epidemiologic research program at Aichi Cancer Center (HERPACC), Japan. Cancer Lett 167:175–182.
   PubMed Web of Science ®Google Scholar
• JV Higdon, and B Frei. (2003). Tea catechins and polyphenols: Health effects, metabolism and antioxidant functions. Crit Rev Food Sci Nutr 43:89–143. b) Mustata GT, Rosca M, Biemel KM, Reihl O, Smith MA, Viswanathan A, Strauch C, Du Y, Tang J, Kern TS, Lederer MO, Brownlee M, Weiss MF, Monnier VM. Paradoxical effects of green tea (Camellia Sinensis) and antioxidant vitamins in diabetic rats. Diabetes 2005;54:517–526. c) Rice-Evans CA, Miller NJ, Paganga G. Structure antioxidant activity relationships of flavonoids and phenolics acids. Free Radic Biol Med 1996;20:933–956
   PubMed Web of Science ®Google Scholar
• MJ Lee, P Maliakal, L Chen, X Meng, FY Bondoc, S Prabhu, G Lambert, S Mohr, and CS Yang. (2002). Pharmacokinetics of tea catechins after ingestion of green tea and ( − )-epigallocatechin-3-gallate by humans: Formation of different metabolites and individual variability. Cancer Epidemiol Biomark Prev 11:1025–1032.
   PubMed Web of Science ®Google Scholar
• IA Siddiqui, F Afaq, VM Adhami, N Ahmad, and H Mukhtar. (2004). Antioxidants of the beverage tea in promotion of human health. Antioxid Redox Signal 6:571–582. b) Whiteside MA, Heimburger DC, Johanning GL. Micronutrients and cancer therapy. Nutr Rev 2004;62:142-147
   PubMed Web of Science ®Google Scholar
• PC Chai, LH Long, and B Halliwell. (2003). Contribution of hydrogen peroxide to the cytotoxiCIT000y of green tea and red wines. Biochem Biophys Res Commun 304:650–654.
   PubMed Web of Science ®Google Scholar
• N Khan, F Afaq, M Saleem, N Ahmad, and H Mukhtar. (2006). Targeting multiple signaling pathways by green tea polyphenol EGCG. Cancer Res 66:2500–2505.
   PubMed Web of Science ®Google Scholar
• ZP Chen, JB Schell, CT Ho, and KY Chen. (1998). Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett 129:173–179. b) Fujiki H. Two stages of cancer prevention with green tea. J Cancer Res Clin Oncol 1999;125:589–597
   PubMed Web of Science ®Google Scholar
• D Gupta, CG Lis, TC Birdsall, and JF Grutsch. (2005). The use of dietary supplements in a community hospital comprehensive cancer centre: Implications for conventional cancer care. Support Care Cancer 13:912–919.
   PubMed Web of Science ®Google Scholar
• A Molassiotis, G Ozden, N Platin, and et al (2006). Complementary and alternative medicine use in patients with head and neck cancer in Europe. Eur J Cancer Care (Engl) 15:19–24.
   PubMed Web of Science ®Google Scholar
• A Molassiotis, P Fernandez-Ortega, D Pud, and et al (2005). Complementary and alternative medicine use in colorectal cancer patients in seven European countries. Complement Ther Med 13:251–257.
   PubMed Web of Science ®Google Scholar
• A Molassiotis, JA Scott, N Kearney, and et al (2006). Complementary and alternative medicine use in breast cancer patients in Europe. Support Care Cancer 14:260–267.
   PubMedGoogle Scholar
• KI Block, AC Koch, MN Mead, PK Tothy, RA Newman, and C Gyllenhaal. (2007). Impact of antioxidant supplementation on chemotherapeutic efficacy: A systematic review of the evidence from randomized controller trials. Cancer Treat Rev 33:407–418.
   PubMed Web of Science ®Google Scholar
• CS Yang. (1999). Tea and health. Nutrition 15:946–949.
   PubMed Web of Science ®Google Scholar
• N Ahmad, and H Mukhtar. (1999). Green tea polyphenols and cancer: Biologic mechanisms and practical implications. Nutr Rev 57:78–83.
   PubMed Web of Science ®Google Scholar
• HH Sherry Chow, IA Hakim, DR Vining, JA Crowell, ME Tome, J Ranger-Moore, CA Cordova, DM Mikhael, MM Briehl, and DS Alberts. (2007). Modulation of human glutathione S-transferase by polyphenon E intervention. Cancer Epidem Biomark 16 (8):1662–1666.
   PubMedGoogle Scholar
• B Pool-Zobel, S Veeriah, and FD Bohmer. (2005). Modulation of xenobiotic metabolising enzymes by anticarcinogens – Focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colerectal carcinogenesis. Mutat Res 591:74–92.
   PubMed Web of Science ®Google Scholar
• P Talalay. (2000). Chemoprotection against cancer by induction of phase 2 enzymes. Biofactors 12:5–11.
   PubMed Web of Science ®Google Scholar
• L Bravo. (1998). Polyphenols: Chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56:317–333.
   PubMed Web of Science ®Google Scholar
• a) NAMD was developed by the Theoretical Biophysics Group in the Beckman Institute for Advanced Science and Technology at the University of Illinois at Urbana-Champaign. b) JC Phillips, R Braun, W Wang, J Gumbart, E Tajkhorshid, E Villa, C Chipot, RD Skeel, L Kale, K Schulten. Scalable molecular dynamics with NAMD. J Comp Chem 2005; 26:1781–1802.
   Google Scholar
• GM Morris, DS Goodsell, RS Halliday, R Huey, WE Hart, RK Belew, and AJ Olson. (1998). Automated docking using a lamarkian genetic algorithm and an empirical binding free energy function. J Comp Chem 19:1639–1662.
   Web of Science ®Google Scholar
• EF Pettersen, TD Goddard, CC Huang, GS Couch, DM Greenblatt, EC Meng, and TE Ferrin. (2004). UCSF Chimera—a visualization system for exploratory research and analysis. J Comp Chem 25:1605–1612.
   PubMed Web of Science ®Google Scholar
• MJ Frisch, GW Trucks, HB Schlegel, GE Scuseria, MA Robb, JR Cheeseman, JA Montgomery, T Vreven, KN Kudin, JC Burant, et al. Gaussian 03. Revision A.1. Pittsburgh, PA: Gaussian; (2003).
   Google Scholar
• WL DeLano. The PyMOL molecular graphics system 2002. San Carlos, CA: DeLano Scientific; (2002). Retrieved from (http://www.pymol.org).
   Google Scholar
• Retrieved from http://www.accelrys.com.
   Google Scholar
• Persistence of Vision Pty. Ltd. Persistence of Vision Raytracer (Version 3.6). Retrieved from http://www.povray.org/download/ 2004.
   Google Scholar
• U Hegazy, K Tars, U Hellman, B Mannervik, PDB code 1J9H.
   Google Scholar
• MF Sanner. (1999). Python: A programming language for software integration and development. J Mol Graphics Mod 17:57–61.
   PubMed Web of Science ®Google Scholar
• HJC Berendsen, JPM Postma, WF van Gunsteren, J Hermans, and B Pullman. Intermolecular forces. Dordrecht: Reidel; (1981).
   Google Scholar
• WL Jorgensen, J Chandrasekhar, J Madura, RW Impey, and ML Klein. (1983). Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926–933.
   Web of Science ®Google Scholar
• S Miyamoto, and PA Kollman. (1992). SETTLE – an analytical version of the shake and rattle algorithm for rigid water models. J Comput Chem 13:952–962.
   Web of Science ®Google Scholar
• B Hess, H Bekker, HJC Berendsen, and JGEM Fraaije. (1997). LINCS: A linear constraint solver for molecular simulations. J Comput Chem 18:1463–1472.
   Web of Science ®Google Scholar
• , and Collaborative Computational Project, Number 4. (1994). The CCP4 suite: Programs for protein crystallography. Acta Cryst D50:760–763.
   Google Scholar
• O Dym, I Xenarios, H Ke, and J Colicelli. (2002). Molecular docking of competitive phosphodiesterase inhibitors. Mol Pharmacol 61:20–25. b) Rao MS, Olson AJ. Modelling of factor Xa-inhibitor complexes: A computational flexible docking approach. Proteins 1999;34:173–183
   PubMed Web of Science ®Google Scholar
• RH Kolm, GE Sroga, and B Mannervik. (1992). Participation of the phenolic hydroxyl group of Tyr-8 in the catalytic mechanism of human glutathione transferase P1-1. Biochem J 285:537–540.
   PubMed Web of Science ®Google Scholar
• KH Kong, M Nishida, H Inoue, and K Takahashi. (1992). Tyrosine-7 is an essential residue for the catalytic activity of human class PI glutathione S-transferase: Chemical modification and site-directed mutagenesis studies. Biochem Biophys Res Commun 182:1122–1129.
   PubMed Web of Science ®Google Scholar
• J Oakley, M Lo Bello, A Battistoni, G Ricci, J Rossjohn, HO Villar, and MW Parker. (1997). The structures of human glutathione transferase P1-1 in complex with glutathione and various inhibitors at high resolution. J Mol Biol 274:84–100.
   PubMed Web of Science ®Google Scholar